Showing results (851-860 of 919) with videos related to
Sort By:
Pageof 92
Journal of Clinical Pathology|March 2, 2016
Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologistsMurali Varma, Lars Egevad, Ferran Algaba, et al.The Oncologist|January 21, 2016
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast CancerEmilio Alba, Ana Lluch, Nuria Ribelles, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 14, 2020
Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort studyAna Garcia Garcia de Paredes, Enrique Rodriguez de Santiago, Carlos Rodriguez-Escaja, et al.Annals of Internal Medicine|November 24, 2025
Interventions to Improve Advance Care Planning Documentation in the Electronic Health Record : A Cluster Randomized TrialAnne M Walling, Rebecca L Sudore, Lisa Gibbs, et al.European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2017
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose LevelsPaolo G Casali, John Zalcberg, Axel Le Cesne, et al.Oncotarget|September 15, 2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutationAnna Caliò, John N Eble, Ondrej Hes, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2023
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, et al.Pageof 92